Application

19395559 · Radiopharmaceutical Compositions Targeting Glypican-3 and Uses Thereof

Filed 2025-11-20 · Granted The official file ↗ · Art unit 1618 · Examiner Dameron Levest Jones Typical · CPC A61K 51/088 · RayzeBio, Inc. · BMS/RayzeBio/McNeill

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

7.2 mo

to disposition 9.4 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.